CTS PSC Cryomedium is a cGMP-manufactured, ready-to-use, xeno-free solution for the cryopreservation of early passage pluripotent stem cells (PSCs). CTS PSC Cryomedium helps minimize loss of cell viability and maximize post-thaw recovery. For the cryopreservation and recovery of PSCs, use the CTS PSC Cryopreservation Kit.

Efficient recovery
CTS PSC Cryomedium routinely achieves higher viability than traditional methods of cryopreservation and is compatible with clump and single cell passaged PSCs cultured in a variety of media systems. CTS PSC Cryomedium is provided as a ready-to-use, complete solution containing 10% DMSO for efficient cell addition. Separate additions of enhancing reagents are not required, helping save valuable preparation time.

Facilitates regulatory filings
CTS PSC Cryomedium is manufactured at a site that uses methods and controls that conform with cGMP for medical devices, 21 CFR Part 820. Our FDA-registered manufacturing site is ISO 13485-certified. Full documentation traceability and convenient access to our Drug Master File (DMF) are available for CTS PSC Cryomedium.

Simplifies transition from bench to clinic
With its extensive safety testing, including adventitious agents, CTS PSC Cryomedium enables a smooth transition from RUO PSC Cryopreservation Medium.

For Research Use or Manufacturing of Cell, Gene, or Tissue-Based Products. CAUTION: Not intended for direct administration into humans or animals.

Quantity:	50 mL
Endotoxin Concentration:	≤1 EU/mL
For Use With (Application):	Pluripotent Stem Cells (PSCs)
Storage Requirements:	Store at -5 to -30°C and protect from light
Sterility:	Sterile